William S. Makarowski

Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen

William S. Makarowski, William W. Zhao, Terry Bevirt et al. · Osteoarthritis and Cartilage · 2002 · 108 citations · Full text

Placebo-controlled Comparison, Pharmacology, Chronic Musculoskeletal Condition +7

Hypothyroidism with presenting symptoms of fibrositis.

William S. Wilke, Leslie R. Sheeler, William S. Makarowski · PubMed · 1982 · 47 citations

Sleep, Myalgic Symptoms, Fibrositis Syndrome +7

Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee

A. Weaver, Bernard Rubin, Jacques Caldwell et al. · Clinical Therapeutics · 1995 · 27 citations

Medicine, Chronic Musculoskeletal Condition, Osteoarthritis +5

The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee

William S. Makarowski · Clinical Therapeutics · 1996 · 15 citations

Anti-inflammatory, Medicine, Chronic Musculoskeletal Condition +5